Home
>
National Drug Code (NDC)
>
RIBASPHERE
RIBASPHERE - 66435-102-95 - (ribavirin)
Drug Information of RIBASPHERE
| Product NDC: | 66435-102 |
| Proprietary Name: | RIBASPHERE |
| Non Proprietary Name: | ribavirin |
| Active Ingredient(s): | 200 mg/1 & nbsp; ribavirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RIBASPHERE
| Product NDC: | 66435-102 |
| Labeler Name: | Kadmon Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077456 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20051205 |
Package Information of RIBASPHERE
| Package NDC: | 66435-102-95 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (66435-102-95) |
NDC Information of RIBASPHERE
| NDC Code | 66435-102-95 |
| Proprietary Name | RIBASPHERE |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (66435-102-95) |
| Product NDC | 66435-102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ribavirin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20051205 |
| Marketing Category Name | ANDA |
| Labeler Name | Kadmon Pharmaceuticals, LLC |
| Substance Name | RIBAVIRIN |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
